This week the FDA has approved a new smartphone ECG device that is capable of detecting three heart arrhythmias takes the form of the AliveCor KardiaMobile. Designed to detect Atrial Fibrillation (AFib) and Normal Sinus Rhythm, AliveCor, is also able to detect and show ECG results for Bradycardia and Tachycardia. “Take a medical-grade EKG anytime, anywhere. In just 30 seconds, detect Atrial Fibrillation, Bradycardia, Tachycardia or Normal heart rhythm”
Providing users with instant analyses to reveal arrhythmias that are not AFib and that are between 40-50 beats per minute (Bradycardia), or between 100-140 beats per minute (Tachycardia). Bradycardia and tachycardia, literally mean “slow heart” and “fast heart”, respectively. AliveCor Chief Executive Officer, Ira Bahr explains more about KardiaMobile.
“No other consumer ECG device in the world, can tell you more about your heart than KardiaMobile. Until today, patients have been frustrated when devices label their ECG reading as ‘unclassified’ or ‘inconclusive.’ Starting today, KardiaMobile is the first personal ECG device that can begin to materially reduce the number of those determinations. Critically, KardiaMobile is also the only personal ECG that can detect Atrial Fibrillation at heart rates above 120, and heart rates below 40.”
“Tachycardia and bradycardia are common because they are often the body’s natural response to everyday life, from physical activity and sleep to emotions and overall health,” said Dr. Jacqueline Shreibati, CMO of AliveCor. “While we have traditionally focused on the patient empowerment that comes from increased awareness of atrial fibrillation, we are excited to give all of our users more actionable insights into their heart health.”
KardiaMobile is the only consumer ECG device in the world with FDA-clearance to detect the three most common heart arrhythmias. For more information jump over to the official AliveCor website.